CompoundedGuide
Verification in progress

AOD-9604

Exact form, route, and dosage not yet verified

Under review

AOD-9604 is listed in the CompoundedGuide registry with no verified FDA-approved product. FDA lists AOD-9604 among bulk drug substances for use in compounding that may present significant safety risks. AOD-9604 is not on FDA's 503B Bulks List for outsourcing facilities (list checked 2026-07-25). Identity and regulatory status are pending source collection and editorial review. This is not medical advice.

What we're checking

Is there an FDA-approved product?
Checking Drugs@FDA, Purple Book, Orange Book
What's the compounding status?
Checking FDA 503A/503B pages, Federal Register
Are there safety signals?
Checking FDA warnings, recalls, FAERS
What does the research show?
Checking ClinicalTrials.gov, PubMed

Sources we need

  • identity: FDA/NCATS GSRS or equivalent canonical identity source
  • product status: Drugs@FDA, Purple Book, Orange Book, DailyMed, or applicable primary FDA record
  • compounding status: FDA 503A/503B pages, Federal Register, docket, or applicable final/interim policy
  • safety: FDA safety communication, warning, recall, FAERS signal context, or explicit absence statement
  • evidence: ClinicalTrials.gov and PubMed/primary publication search
  • state or facility: State board or FDA facility record when relevant

Sources checked

Captured from the source and re-checked against it. Not yet editorially reviewed.

For developers
JSON record Markdown Source packet